ODP484 Hyperthyroidism During Prostaglandin I2 Treatment in Pulmonary Hypertension and Its Molecular Mechanism

Continuous intravenous infusion of prostaglandin I2 (PGI2) analog, epoprostenol, has improved the survival rate for severe pulmonary hypertension, but longer treatment with PGI2 sometimes occurs hyperthyroidism. For the hyperthyroidism during PGI2 treatment, two molecular mechanisms are speculated;...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishida, Emi, Yoshikawa, Masashi, Hiraga, Haruna, Nishikido, Ayaka, Toki, Akiko, Horiguchi, Kazuhiko, Matsumoto, Shunichi, Yoshino, Satoshi, Ozawa, Atsushi, Yamada, Masanobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625130/
http://dx.doi.org/10.1210/jendso/bvac150.1584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625130/
http://dx.doi.org/10.1210/jendso/bvac150.1584

Ejemplares similares